Viewing Study NCT00141765



Ignite Creation Date: 2024-05-05 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00141765
Status: COMPLETED
Last Update Posted: 2014-06-20
First Post: 2005-08-31

Brief Title: Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
Sponsor: University of Michigan Rogel Cancer Center
Organization: University of Michigan Rogel Cancer Center

Study Overview

Official Title: Myeloablative Chemotherapy With Stem Cell Rescue for Rare Poor-Prognosis Cancers
Status: COMPLETED
Status Verified Date: 2014-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether very high dosages of chemotherapy will improve the chance of surviving cancer
Detailed Description: This is a phase II trial designed to provide a transplant option for patients with rare poor-prognosis cancers The protocol is only open to patients with metastatic or relapsed cancers for whom the probability of remaining free of progressive disease for one year after being brought into remission is 25 Patients eligible for this study have been diagnosed with a form of cancer that leads to death more than 75 of the time when treated with standard therapy doses of chemotherapy and or radiation therapy Under this treatment intensification protocol the expectation is that the one year progression-free survival for this group of patients will rise to 40 Patients eligible for this protocol will be followed for one year post-transplant Patients alive and free of progressive disease at the end of this period will be considered successes

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
IRB 1996-195 None None None